Category: pharma & healthcare

Here we examine one such case of a 72-year-old patient who was infected continuously for two months, as detailed by Truffot et al.

A new report, led by researchers with the Oak Ridge National Laboratory, prompts us to shift our focus towards the entirety of the viral genome, rather than just the S protein.

This is the third in our series that outlines what we know about Omicron. We summarize the finding of recent experiments by Cameroni et al. in a bioRxiv preprint from December 14th.

A recent study has found that blood transfusions from highly active mice into sedentary mice boosted brain function in the sedentary recipients. This discovery may mark a significant step in uncovering treatments to slow the progression of neurodegener…

Results of a preliminary study show that we may be one step closer to achieving a cure for Type 1 diabetes.

Public health officials are seeking to optimize timing of a Covid-19 vaccine boosters. Specifically, they’re trying to figure out what’s optimal in terms of spacing between the second and third doses of vaccine. Differences in scheduling across countri…

This is the second of a two-part series. In part one, we described the mutations in the Omicron Spike protein. In part two, we will describe mutations in other parts of the genome.

Immunocompromised Americans who are not adequately protected by their Covid-19 vaccination series will now have an additional option for long-term protection in the form of an antibody cocktail drug developed by AstraZeneca.

Ron Johnson promotes Covid-19 conspiracy theories and the use of drugs that have shown no evidence that they are effective. His latest foray into quackery – promotion of Listerine as a Covid-19 treatment – encapsulates the rising tide of anti-science t…

Omicron is sending a message, loud and clear: this virus is capable of far more changes and far more variation than most ever thought possible and it will keep coming back to haunt us again and again.